Author name: Yali Friedman

Pharma Financial Squeeze Bodes Ill for Genomics ‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general […]

DeCode’s Genetic Breakthrough Barely Registers DeCode Genetics published an important genetic map–assembled by methods very different from those used to

DeCode’s Genetic Breakthrough Barely Registers DeCode Genetics published an important genetic map–assembled by methods very different from those used to

Celera abandons gene sequencing The company that shared the glory for unravelling the code of life of human beings has

Biotrends Two major reports highlight the globalization of biotechnology and the battle within the U.S. for regional supremacy

Where the Biotech Bets Are John McCamant of The Medical Technology Stock Letter tells where he’s making his in this

Biotech lobbyists’ clout grows in Washington The Biotechnology Industry Organization is still unpacking from its move into a bigger office

Biotech lobbyists’ clout grows in Washington The Biotechnology Industry Organization is still unpacking from its move into a bigger office

Gene Doping Threatens to Transform Sports “If it does take off, sport as we know it will disappear”

FDA Acts To Speed Bioterror Medicines Responding to the threat of anthrax and other forms of chemical and biological terrorism,